Zentalis Pharmaceuticals Inc.
ZNTL | NASDAQ
$3.03
-$0.08 (-2.57%)
At close: Sep 21, 2026, 4:00 PM ET
$3.10
+$0.07 (+2.31%)
Pre-market:
Sep 22, 2026, 8:36 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.71 | -1.30 | -3.39 | -4.50 | -22.60 | -18.10 |
PEG Ratio | 0.04 | 0.03 | 15.18 | -0.22 | -0.76 | -0.15 |
PS Ratio | n/a | 3.19 | n/a | n/a | n/a | n/a |
PB Ratio | 0.45 | 0.64 | 2.27 | 2.45 | 9.86 | 6.91 |
P/FCF Ratio | -0.77 | -1.26 | -4.75 | -6.40 | -22.40 | -24.34 |
P/OCF Ratio | -0.77 | -1.26 | -4.77 | -6.50 | -23.29 | -24.55 |
OCF/S Ratio | n/a | -253.41 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.18 | 0.13 | 0.10 | 0.11 | 0.13 | 0.01 |
Quick Ratio | 6.93 | 7.32 | 7.16 | 7.98 | 7.98 | 12.07 |
Current Ratio | 6.93 | 7.32 | 7.16 | 7.98 | 7.98 | 12.07 |
Asset Turnover | n/a | 0.16 | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -88.27 | n/a | n/a |
Return on Equity | -63.39% | -49.18% | -66.82% | -54.59% | -43.61% | -38.19% |
Return on Assets | -47.43% | -38.54% | -51.99% | -42.79% | -33.63% | -32.24% |
Return on Invested Capital | -59.63% | -50.22% | -60.35% | -45.46% | -50.32% | -35.16% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 100% | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -245.96% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -245.74% | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -283.57% | n/a | n/a | n/a | n/a |
FCF Margin | n/a | -253.74% | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -276.11% | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ZNTL